Book an Appointment
Retinitis Pigmentosa (RP), known medically as “Tavuk Karası,” is a hereditary eye disease characterized by the progressive degeneration of photoreceptor cells in the retinal layer. This condition leads to difficulty seeing, especially at night or in low-light conditions, and is also commonly known as night blindness.
Night blindness, as a symptom of RP, typically begins to manifest in childhood or young adulthood. In the initial stage, the light-sensitive rod cells of the retina are affected, which causes a decrease in night vision. As the disease progresses, the cone cells can also be damaged, leading to impairments in central and color vision. Consequently, patients may experience a loss of peripheral vision, referred to as tunnel vision.
Retinitis Pigmentosa is a rare disease, affecting approximately one in every 4,000 people worldwide. The rate and severity of the disease’s progression can vary among individuals depending on genetic factors. While complete blindness is rare, severe vision loss can occur in the advanced stages.
Table of Contents
Currently, there is no definitive cure for Retinitis Pigmentosa. However, various research and clinical trials are ongoing to slow the progression of the disease and improve quality of life. Regular eye check-ups and genetic counseling play a significant role in the management of the disease.
Retinitis Pigmentosa is a serious eye disease that occurs due to the genetic deterioration of retinal cells and can lead to progressive vision loss. Early diagnosis and appropriate management strategies can significantly impact patients’ quality of life.
Is Retinitis Pigmentosa Genetic?
Yes, Retinitis Pigmentosa (RP) is a genetic eye disease and can be transmitted through different inheritance patterns:
- Autosomal Dominant Inheritance: In this pattern, only a single copy of the mutated gene is sufficient for the disease to manifest. Affected individuals are typically seen in every generation, and the risk for each child to inherit the disease is 50%.
- Autosomal Recessive Inheritance: For the disease to manifest, the mutated gene must be inherited from both parents. The carrier parents usually do not show symptoms of the disease, but the risk for each child to inherit the disease is 25%.
- X-Linked Inheritance: The mutation is located on the X chromosome. Males (with an XY chromosome structure) will manifest the disease if they carry a single mutated X chromosome. Females (with an XX chromosome structure) are generally carriers and do not show symptoms, although they may experience mild symptoms in some cases.
Retinitis Pigmentosa is a genetically diverse disease, with over 1,000 mutations identified in more than 25 genes. It is important for individuals with a family history of RP to receive genetic counseling and undergo regular eye examinations.
What Causes Night Blindness?
Night blindness (nyctalopia) generally occurs as a symptom of an underlying eye disease and does not mean complete blindness.
Causes of Night Blindness:
- Genetic Factors: Hereditary diseases like Retinitis Pigmentosa can cause severe damage to the vision-responsible cells in the retina, leading to night blindness.
- Vitamin A Deficiency: Vitamin A plays a critical role in the production of molecules in the retina’s light-sensitive area that convert nerve impulses into images. Insufficient Vitamin A intake, especially in conditions where fat digestion is impaired such as pancreatic insufficiency or cystic fibrosis, can cause impairments in night vision.
- Glaucoma: Glaucoma, characterized by increased intraocular pressure, can damage the optic nerve and negatively affect night vision. Additionally, some medications used to treat glaucoma can cause the pupil to constrict, leading to night blindness.
- Cataracts: Cataracts, which occur when the ocular lens loses its transparency, can cause night blindness by reducing the quality of vision, especially at night or in dim light.
- Diabetes Mellitus: High blood sugar levels can lead to retinal damage, causing diabetic retinopathy. This condition can result in decreased night vision and other vision problems.
Correctly identifying the underlying causes of night blindness is critically important for creating an effective treatment plan. Therefore, it is important to consult an ophthalmologist when symptoms are noticed.
Symptoms of Night Blindness (Nyctalopia)
Nyctalopia, the medical term for night blindness, is a condition of experiencing difficulty seeing in low-light conditions or dark environments. This condition typically arises as a symptom of an underlying eye disease and does not imply complete blindness.
- Difficulty Seeing in the Dark: Individuals with RP experience problems seeing clearly in dimly lit environments or at night. This symptom becomes particularly noticeable in situations such as movie theaters, poorly lit restaurants, or while driving at night.
- Narrowing of the Visual Field (Tunnel Vision): As the disease progresses, a decrease in peripheral vision occurs. This creates the sensation of having a narrow field of vision, as if looking through a tunnel.
- Seeing Light Rings (Halos): Bright rings or light scattering may be seen around the headlights of oncoming cars or streetlights, especially when driving at night.
- Impaired Color Perception: People with night blindness may have difficulty distinguishing certain colors, especially shades of blue and green. The perception of colors as faded or different is among the symptoms of the disease.
- Eye Fatigue: Being in dark or dim environments for extended periods can cause the eyes to tire more quickly than normal. This fatigue can manifest as discomfort in the eyes and difficulty focusing.
The symptoms of Retinitis Pigmentosa can vary depending on the underlying cause and may progress over time. Therefore, it is important for individuals experiencing such symptoms to consult an ophthalmologist for a detailed examination.
Retinitis Pigmentosa Testing
Retinitis Pigmentosa is a genetic eye disease characterized by the progressive loss of photoreceptor cells in the retina. The following tests are used for diagnosis:
- Visual Field Test: This test is used to identify constrictions and scotomas (blind spots) in the patient’s visual field. Since peripheral vision loss (also known as tunnel vision) is common in Retinitis Pigmentosa patients, visual field tests are critically important for its detection.
- Electroretinography (ERG): The ERG is a test that measures the electrical activity of the photoreceptor cells (rods and cones) in the retina. Through electrodes placed on the ocular surface, the retina’s responses to light stimuli are recorded. In Retinitis Pigmentosa patients, a decrease or loss in the function of rod cells, in particular, is detected. The ERG plays a significant role in diagnosis as it can detect abnormalities even in the early stages of the disease.
- Genetic Testing: Retinitis Pigmentosa can be caused by many genetic mutations with different inheritance patterns. Genetic tests are used to identify the specific gene mutations causing the disease. These tests help in understanding the inheritance pattern of the disease (autosomal dominant, autosomal recessive, X-linked, etc.) and its prognosis. They also guide genetic counseling and future treatment options.
The combination of these tests is critically important for confirming the diagnosis of Retinitis Pigmentosa and monitoring the course of the disease. Early diagnosis guides patients and their families on the measures to be taken to slow the progression of the disease and improve quality of life.
Retinitis Pigmentosa Treatment
Although there is no definitive cure for Retinitis Pigmentosa, various methods are used to slow the progression of the disease:
Recent Developments in Treatment
- Gene Therapy: Aims to repair damaged genes by targeting genetic mutations. FDA-approved gene therapies like Luxturna have shown effective results in patients carrying the RPE65 mutation.
- CRISPR Technology: This method, which aims to correct hereditary disorders by editing DNA sequences, is showing promise in clinical trials.
- Vitamin Supplements: High doses of Vitamin A palmitate, in particular, may help preserve night vision in some types of RP. However, the dosage must be supervised by a physician.
- RNA Therapies: This new technique, developed to prevent vision loss due to specific gene mutations, provides intervention at the cellular level.
Night Blindness Glasses
Glasses specially designed for individuals experiencing night blindness aim to enhance vision in low-light conditions. These glasses typically have yellow or amber-tinted lenses and aim to increase contrast by filtering blue light. Additionally, they provide a clearer view by reducing glare with anti-reflective coatings.
However, scientific research on the effectiveness of such glasses is limited. A study conducted by the Schepens Eye Research Institute in Boston stated that night driving glasses did not provide a significant benefit in simulated night driving conditions. On the other hand, some users report that these glasses reduce glare and improve vision during night driving.
The effectiveness of glasses designed for Retinitis Pigmentosa can vary from person to person. Therefore, it is important to consult an eye care professional before using such a product.
- Yellow and Amber Tinted Lenses: Increase contrast by filtering blue light.
- Polarized Lenses: Provide a clearer view by reducing glare.
- UV400 Protection: Protects the eyes from harmful UV rays.
- Photochromic (Day/Night) Lenses: Automatically darken according to light conditions.
Surgical and Advanced Procedures for Night Blindness
In patients with advanced-stage Retinitis Pigmentosa, surgical options may be considered. Specifically, retinal implants or lens replacement operations can improve visual ability.
- Retinal Implants: Bionic eye implants like the Argus II partially restore vision by converting light signals into electrical signals.
- Artificial Lens Surgeries: Used to prevent secondary problems such as cataracts.
- Optogenetic Therapy: An experimental method that aims to enhance visual function by making retinal cells light-sensitive.
Stem Cell Therapy for Retinitis Pigmentosa
Stem cell therapy for RP aims to regenerate damaged retinal cells. This treatment has been recognized as a significant development in the field of night blindness therapy in recent years.
- SCOTS (Stem Cell Ophthalmology Treatment Study): In this study, a significant improvement in visual function was observed in a portion of the patients.
- Mesenchymal Stem Cells (MSCs): Can help restore the function of photoreceptor cells by regenerating retinal tissue.
- iPSCs (Induced Pluripotent Stem Cells): These stem cells, derived from the person’s own cells, offer a safer treatment option by preventing immunological rejection.
Foods That Are Good for Retinitis Pigmentosa
Nutrition plays an important role in slowing the progression of Retinitis Pigmentosa:
- Vitamin A: Supports the rhodopsin pigment, which is critical for eye health. Found in foods like carrots, spinach, and sweet potatoes.
- Omega-3 Fatty Acids: Protect retinal functions and reduce inflammation. Salmon, walnuts, and flaxseed are important sources.
- Vitamin C: Prevents retinal damage caused by free radicals. Consumption of oranges, strawberries, and broccoli is recommended.
- Vitamin E: Protects retinal cells from oxidative stress. Almonds, sunflower seeds, and avocados are rich sources.
- Zinc: Supports visual function by protecting retinal health. Nuts like pumpkin seeds and cashews are recommended.
- Lutein and Zeaxanthin: Reduce damage from blue light and support retinal health. Found in foods like egg yolks, corn, and spinach.
Current research in the treatment of Retinitis Pigmentosa shows that gene therapy, stem cell therapy, and healthy nutrition play a significant role in slowing the progression of the disease. Early diagnosis and regular check-ups are critically important for preventing vision loss.
The text and images on our site are for informational purposes only. They do not substitute for diagnosis and treatment, nor do they carry any legal responsibility.